Immunological outcome measures

European Respiratory Journal, Supplement

Volumn 9, Issue 21, 1996, Pages

  Bjorksten B ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Immunoglobulin E; Immunological markers; Infants prediction

Indexed keywords

ALLERGEN; BIOCHEMICAL MARKER; IMMUNOGLOBULIN E; ANTIIDIOTYPIC ANTIBODY;

ANTIBODY DETECTION; ASTHMA; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT OUTCOME; WHEEZING; ABNORMAL RESPIRATORY SOUND; BRONCHUS HYPERREACTIVITY; IMMUNOLOGY; INFANT; INHALATION TEST; PATCH TEST; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTI-IDIOTYPIC; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN E; INFANT; PATCH TESTS; PREDICTIVE VALUE OF TESTS; RESPIRATORY SOUNDS; SENSITIVITY AND SPECIFICITY;

EID: 0030116405     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Holt PG. Environmental factors and primary T-cell sensitisation to inhallent allergens in infancy; reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995; 6: 1-10.
2. Dreborg S, Frew A. Position paper: allergen standardization and skin tests. Allergy 1993; 48 (Suppl. 14): 49-82.
3. Stewart G, Thompson P, McWilliams A. Biochemical properties of aeroallergens: contributory factors in allergic sensitization? Pediatr Allergy Immunol 1993; 4: 163-172.
4. Hattevig G, Kjellman B, Björkstén B, Johansson SGO. The prevalence of allergy and IgE antibodies to inhalant allergens in Swedish school children. Acta Paediatr Scand 1987; 76: 349-355.
5. Hattevig G, Kjellman B, Björkstén B. Appearance of IgE antibodies to ingested and inhaled allergens during first 12 years of life in atopic and nonatopic children. Pediatr Allergy Immunol 1993; 4: 182-189.
6. van Asperen PP, Kemp AS. The natural history of IgE sensitization and atopic disease in early childhood. Acta Paediatr Scand 1989; 78: 239-245.
7. Nolte H. The clinical utility of basophil histamine release. Allergy Proc 1993; 14: 251-254.
8. Björkstén B, Kjellman N-IM. Immunological abnormalities in atopic infants. Allergologie 1989; 12 (Suppl.): 176-179.
9. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Appl Immunol 1992; 98: 279-285.
10. Borres M, Einarsson R, Björkstén B. Serum levels of interleukin-4, soluble CD23 and IFN-gamma in relation to the development of allergic disease during the first 18 months of life. Clin Exp Allergy 1995; 25: 543-548.
11. Tang MLK, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-γ secretion in neonates and subsequent atopy. Lancet 1994; 344: 983-985.
12. Tang MLK, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic and nonatopic children with asthma. Clin Exp Allergy 1995; 25: 515-521.
13. Matsumoto T, Miike T, Yamaguchi K, Murakami M, Kawabe T, Yodoi J. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic disease. Clin Exp Immunol 1991; 85: 288-292.
14. Rinas U, Horneff G, Wahn V. Interferon-gamma production by cord-blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE-levels. Pediatr Allergy Immunol 1993; 4: 60-64.
15. Hvatum M, Scott H, Brandtzaeg P. Pitfalls in determining IgG and IgG subclass antibodies to food antigens. J Immunol Methods 1992; 148: 77-85.
16. Björkstén B. In vitro diagnostic methods in the evaluation of food hypersensitivity. In: Metcalfe D, Sampson H, eds. Adverse Reactions to Foods and Food Additives. Cambridge, MA; Blackwell Scientific Publications, 1991; pp. 67-80.
17. Stadler BM. Anti-IgE autoantibodies: a possible specific feedback on the cytokine network in allergy? Eur Cytokine Netw 1992; 3(5): 437-441.
18. Vassella C, Odelram H, Kjellman N-I, Borres M, Vanto T, Björkstén B. High anti-IgE levels at birth are associated with a reduced allergy incidence in early childhood: a prospective study. Clin Exp Allergy 1994; 24: 771-777.
19. Rimås M, Gustafsson P, Kjellman N-I, Björkstén B. Conjunctival provocation test: high clinical reproducibility but little temperature change. Allergy 1992; 47: 324-326.
20. Möller C, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984; 39: 37-41.
21. Pipkorn U. Pharmacological influence of antiallergic medication on in vivo allergen testing. Allergy 1988; 43: 81-86.
22. Charpin D, Birnbaum J, Haddi E, et al. Altitiude and allergy to house-dust mites: a paradigm of the influence of environmental exposure on allergic sensitization. Am Rev Respir Dis 1991; 143: 983-986.
23. Arshad S, Matthews S, Gant C, Hide D. Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 1992; 339: 1493-1497.
24. Hide DW, Matthews S, Matthews L, et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years. J Allergy Clin Immunol 1994; 93(5): 842-846.
25. Sporik R, Holgate ST, Plats-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study. N Engl J Med 1990; 323: 502-507.
26. Björkstén B. Risk factors in early childhood for the development of atopic diseases. Allergy 1994; 49: 400-407.